secwatch.observer — SEC 8-K summary
======================================

Issuer:     PRECISION BIOSCIENCES INC (DTIL)
CIK:        0001357874
Form:       8-K
Filed at:   2026-05-26T21:20:29+00:00
Accession:  0001628280-26-038220
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Precision BioSciences shareholders approve 3.8M share increase for equity plan; elect directors
--------------------------------------------------------------------------------

- Shareholders approved amendment to 2019 Incentive Award Plan, increasing share reserve by 3.8M shares (58% for, 42% against).
- Amendment to certificate of incorporation approved (17.9M for, 1.4M against) to allow officer exculpation under Delaware law.
- Melinda Brown and Geno Germano elected as Class I directors (14.3M and 14.3M votes for respectively).
- Ratified Deloitte & Touche as independent auditor for FY2026 (22.2M for, 99k against).
- Advisory say-on-pay approved (18.7M for, 613k against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357874/000162828026038220/0001628280-26-038220-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357874/000162828026038220/dtil-20260521.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-038220

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer